# SV2 PET Imaging With [11C]APP311

> **NCT03995121** · — · RECRUITING · sponsor: **Yale University** · enrollment: 250 (estimated)

## Conditions studied

- Schizophrenia and Other Psychotic Disorders
- Cannabis Use Disorder
- Healthy

## Interventions

- **DRUG:** [11C]APP311

## Key facts

- **NCT ID:** NCT03995121
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-12-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03995121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03995121, "SV2 PET Imaging With [11C]APP311". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03995121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
